Effect of an L-carnitinecontaining peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial
GLP-1 drugs can be life-changing for people with obesity or diabetes
a follow-up will run through 240 weeks
Insgesamt stellen sich die GLP-1-RA als hochwirksame glukosesenkende Medikamente dar, die zustzlich eine erhebliche und stoffwechselrelevante Gewichtsreduktion untersttzen knnen und bei einer recht groen Subpopulation aller Menschen mit T2D schwerwiegende kardiovaskulre Ereignisse verhindern knnen
For those who do interact with patients, remember to be sensitive to your patients with obesity as they have many challenges beyond just those for which they may be consulting you
Spotify: Apple: Youtube: To view or add a comment, sign in This week's practice news: University of Otago Webinar: Travel medicine unpacked plus online papers in primary health care or travel medicine in 2026 Postgraduate primary health care and travel medicine qualifications Australian Prescriber Podcast: Choosing a nonsteroidal anti-inflammatory drug (NSAID) for pain PSNZ members read more: To view or add a comment, sign in Cholesterol Medication | Why You Shouldnt Adjust It Yourself | Dr
